Opening book details…
About this Medicine article
Phase 1 study of investigational oral mTORC1/2 inhibitor TAK-228 (MLN0128): Tolerability and food effects of a milled formulation in patients (pts) with advanced solid tumors by Moore, K.N. ;Bauer, T.M. ;Falchook, G. ;Patel, C. ;Neuwirth, R. ;Enke, A. ;Zohren, F. ;Patel, M.R. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Moore, K.N. ;Bauer, T.M. ;Falchook, G. ;Patel, C. ;Neuwirth, R. ;Enke, A. ;Zohren, F. ;Patel, M.R.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2016
- Language
- EN
- Field
- Medicine (Health Sciences)